On-Demand Webinars

HomeEducationOn-Demand Webinars

Welcome to the ILCA Webinar Series On-Demand page. Here, you can access all of our past webinars covering a range of topics relevant to liver cancer treatment and care. Our on-demand webinars offer a flexible and convenient learning experience that allows you to access high-quality educational content at your convenience.

ILCA Webinar Series 2024
On-Demand Webinars

Systemic treatment for advanced HCC: How to choose and sequence systemic therapies for advanced HCC of moving immunotherapy for HCC into earlier scenarios/How to treat special populations

What’s the best approach to treating advanced HCC? In this webinar, Arndt Vogel, Anna Saborowski, Bernhard Scheiner and Katie Kelley explore how to choose and sequence therapies, emphasising treating special patient populations.

Watch on-demand >

On-Demand Webinars
The complex goal of moving immunotherapy for HCC into earlier scenarios

What are the challenges and strategies for advancing immunotherapy in HCC to earlier treatment stages and improving patient outcomes?

In this webinar, co-chaired by Peter Galle and Marco Sanduzzi-Zamparelli, we discussed the latest advancements and clinical strategies in this rapidly evolving field.

Watch on-demand >

On-Demand Webinars
Integrating Hepatocellular Carcinoma Therapies in Resource-Limited Settings

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Pediatric Liver Cancer

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
TACE plus Systemic Therapy: Ready to Use?

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Genome-based treatment of HCC resistant to treatment

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Updates in Liver Transplantation for Hepatocellular Carcinoma and Cholangiocarcinoma. What’s new in 2024?

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Advances in radiotherapy in hepatocellular carcinoma

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Digital pathology and multiomics age for biomarkers discovery in HCC

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Portal Hypertension Issues in Hepatocellular Carcinoma

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

ILCA Webinar Series 2023
On-Demand Webinars
Update on Rare Primary Liver

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

LCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
TACE Guidance

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

LCA Members: click here  to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Immunotherapy for early intermediate HCC

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Screening and Treatment of Gastroesophageal Varices Prior to Systemic Therapy for HCC

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Deciphering NASH-HCC development and response to therapy

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Role of Microbiome in Liver Cancer

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Advances in surgical therapy for HCC

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Intrahepatic cholangiocarcinoma: novel epidemiology, diagnosis and treatment opportunities – in SPANISH

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Radioembolization of HCC in 2023

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
We regret to inform you that the webinar introduction is not included in the recording due to unforeseen technical difficulties beyond our control. We apologize for any inconvenience caused.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Clinical trial designs for the development of new drugs for liver cancer (HCC and CC)

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Liver transplant for CCA

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
New IO targets in liver cancer

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Targeted therapies and immunotherapy for unresectable BTC/CCA

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

On-Demand Webinars
Benefits and risks of systemic therapy for patients with HCC awaiting liver transplantation

This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.

ILCA Members: click here to access the webinar

Non-Members: click here to purchase the webinar

ILCA Webinar Series 2022

Novel emerging therapies for advanced HCC

Tuesday 13 December, 2022

In this webinar, our experts will discuss:

  • Existing data and current developments on the combination of systemic and locoregional therapies in HCC
  • Future therapeutic directions in HCC

Recommendations for practicing TACE

Tuesday 8 November, 2022

During this symposium, the latest role of TACE in the context of recent development of systemic therapy and the new data regarding TACE use will be discussed. Participants will hear more about new concepts on applying TACE in the treatment of  HCC, on the maximization of TACE’s benefits in HCC patients and on the standardization in administering TACE in clinical practice and research. We will also present the ILCA TACE consensus and its clinical impact. Attendees will have the opportunity to learn key areas from experts in the field:

  • Refinement of TACE to suitable population
  • Standardization of TACE technique
  • Consensus on the retreatment and stopping criteria of TACE

Recent developments in targeted therapies in BTC

Tuesday 11 October, 2022

During this webinar, current recommendations for molecular profiling in biliary tract tumours will be summarised, together with latest trial data supporting the use of targeted therapies strategies in this scenario. We will also have dedicated time to review and discuss ongoing challenges, not only for molecular profiling but also for the use of targeted therapies and how the future looks like in this setting.

Taking that next step: Tips on how to become an independent researcher and lead your own projects

Thursday 22 September, 2022

Hear from young stars in the field of liver cancer research as they share their career journeys to becoming independent. They will discuss topics including:

  • How to lead your own projects and be the PI/senior author
  • How to break free from being reliant on your supervisors
  • Securing funding
  • Finding your research niche

Tumor Heterogeneity in HCC analyzed by Single Cell Analysis

Thursday 16 June, 2022

Three experts in the liver cancer and single cell analysis came together and discussed latest research findings  on:

  • HCC and iCCA
  • Immune cell interaction with hepatocytes
  • Find out about the rest in the webinar…

Clinical Applications for Liquid Biopsy in Hepatocellular Carcinoma

Tuesday 10 May, 2022

During the webinar  we learned more about the potential role of liquid biopsy across the spectrum of HCC, and topics including:

  • What is liquid biopsy?
  • The role of liquid biopsy for HCC detection
  • and more to find out in on-demand webinar

Tips from the editor’s desk: How to succeed in the peer review process

Tuesday 12 April, 2022

5 Senior Editors from top journals in hepatology and oncology come together to discuss all aspects of the peer review process, including:

  • How to be a good peer reviewer
  • How to review revised manuscripts
  • Formatting revised manuscripts and responses to reviewers
  • Discussing questions around revisions or acceptance decisions with the editor

Neoadjuvant and Adjuvant Immunotherapy in HCC

Thursday 10 March, 2022

The use of immunotherapy in the treatment of cancer has rapidly increased and is approved to treat HCC in the advanced stage. This has led to a growing interest in their clinical use. This webinar summarises the current evidence and the gaps in knowledge.

  • Rationale and surgical perspective
  • Facts, Challenges, and future directives

Systemic Therapy for Advanced HCC Continues to Evolve Rapidly

Tuesday 8 February, 2022

  • Durva Tremi: a new first-line option for advanced HCC?
  • What is the future for combining checkpoint inhibitors and TKIs?
  • What is the role for single agent TKI first-line?

Primary and acquired resistance to immunotherapy in HCC: From research to practice

Thursday 11 November, 2021

  • How can animal models help better understand primary and secondary resistance to immune checkpoint inhibitor therapy
  • Combination Strategies to Address Immune Checkpoint Inhibitor Resistance in Advanced HCC
  • Insight from neoadjuvant and adjuvant trials of immunotherapy

Systemic therapy of CCA. Patho-molecular profile meets treatment choices

Monday 27 September, 2021

  • Pathology of CCA
  • Molecular characterization, actionable genetic alterations
  • Targeted therapies including immunotherapy given recent promising early phase data with lenva-pembro or IO+chemo and ongoing phase 2-3 trials
On-Demand Webinars

Radiation oncology in the management of HCC. Who and how should be treated.

Thursday 17th June, 2021
Duration: 1 hour

Best of ILCA 2020

As 2021 gets into gear, ILCA’s liver cancer experts present this webinar based on key selected sessions of the ILCA 2020 Annual Conference.

Thursday 25th February, 2021
Duration: 1 hour

Management Of Hcc During Covid-19: ILCA Guidance

Our expert presenters discussed the current data on COVID-19-related liver disease and the impact of SARS-CoV-2 infection in patients with chronic liver diseases.

Friday 17th April, 2020
Duration: 1 hour

         
    • Session Recordings Now Available - Relive #STW25
    • Save the date for ILCA School of Liver Cancer | 19-20 December 2025 | India
    • Registrations open | ILCA 2025 Annual Conference | 19-21 November 2025, Hong Kong
    x